The Rare Cancers Conference 2026: Advances in Diagnosis, Genomics, and Targeted Therapies for Rare and Orphan Malignancies, organized by Binaytara, will take place on November 14, 2026, at Hotel Nikko San Francisco in San Francisco, California.

This CME/CE-accredited multidisciplinary conference will focus on improving the diagnosis and management of rare and orphan malignancies through advances in molecular diagnostics, next-generation sequencing, biomarkers, precision oncology, targeted therapies, immunotherapy, hereditary cancer risk assessment, and multidisciplinary care.

The programme will include expert-led sessions and case-based discussions on topics such as molecular taxonomy of rare cancers, germline risk, precision therapy, rare tumor boards, immunotherapy, CAR T-cell therapy, and rapid updates across sarcoma, rare GI and hepatobiliary cancers, neuroendocrine tumors, CNS tumors, and rare head and neck and thoracic malignancies.

The conference is intended for medical oncologists, hematologist-oncologists, advanced practice providers, oncology pharmacists, researchers, fellows, and other professionals involved in rare cancer care.